Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to follow-up with participants from feeder studies who achieved
sustained virologic response (SVR) over 24 hours posttreatment (SVR24), to assess durability
of SVR, and to assess the changes in liver disease, development of hepatocellular carcinoma
and post-treatment safety over time.
Participants enter this study from feeder studies CDEB025A2210 (NCT01183169), CDEB025A2301
(NCT01318694), and CDEB025A2211 (NCT01215643). They return to the site for up to 48 weeks
with a maximum of 3 visits. No treatment is involved.